非铂类金属抗肿瘤药物的研究进展

自从顺铂被发现具有抗肿瘤活性以来,金属抗肿瘤药物得到了飞速的发展,一些非铂类金属的化合物也相继被发现具有一定的抗肿瘤活性。与铂类金属药物相比,非铂类金属抗肿瘤药物的发展相对缓慢,但也取得了一定的成果。本文主要就一些已经进入临床试验阶段的非铂类抗肿瘤药物的研究进展作一简述。     

氟尿嘧啶自旋标记衍生物的合成与抗肿瘤活性

稳定氮氧自由基作为某些抗癌药物的载体,不仅能提高药物对癌细胞的选择性,而且为借助电子自旋共振(ESR)技术研究药物的作用机理和代谢提供了一种新手段。在前文中,我们报道了几种5-氟尿嘧啶的自旋标记衍生物。作为这一工作的继续,本文报道一系列新的氟尿嘧啶自旋标记衍生物10_(a—c)、11_(a—c)和12_(a—c)的合成及其抗肿瘤活性的研究。     

Naphthalimides and analogues as antitumor agents: A review on molecular design,bioactivity and mechanism of action

Our research improves the structure diversity of naphthalimide antitumor agents and distinct variances of antitumor targets and mechanism of action.     

Design, Synthesis and Synergistic Effects of Novel Derivatives of Solanesol

To further explore the biological activities of solanesylamine derivatives,several novel solanesylpiperazinotriamines and their amides were designed and synthesized,the chemical structures of target compounds were confirmed by IR,1H NMR,MS,and element analysis.The in vitro antitumor activities of the synthetic compounds were assessed by MTT test on L1210 and CHO cells.The preliminary results showed that at low micromolar concentrations these compounds exhibit obvious toxicity against tumor cells,and the synergistic effect on clinical antitumor agent indicated that at noncytotoxic concentrations,they also evidently enhance the curative effect of vincristine(VCR).The synergistic effects of compounds 4a,4c,and 9 were even superior to that of reference compound N,N'-bis(3,4-dimethoxybenzyl)-N-solanesyl-ethylenediamine(SDB).     

DNA Metalating–Intercalating Hybrid Agents for the Treatment of Chemoresistant Cancers

Nonclassical platinum‐based antitumor agents have shown enormous potential in the treatment of chemoresistant cancers. The design of these agents is based on the hypothesis that platinum‐containing pharmacophores that react with nuclear DNA in cancer cells radically differently than the clinical agent cisplatin will produce a unique spectrum of biological activity. One such class of molecules are platinum–acridine hybrid agents derived from the prototypical complex [PtCl(en)(ACRAMTU)](NO₃)₂, en=ethane‐1,2‐diamine, ACRAMTU=1‐[2‐(acridin‐9‐ylamino)ethyl]‐1,3‐dimethylthiourea (“PT–ACRAMTU”). This article summarizes milestones in the development of these agents and reviews critical key concepts that have guided their design and that of related compounds.     

Synthesis of Novel Derivatives of 1,5-Dihydro-4,6-dithio-l,3,5,2-triazaphosphorine-2-oxide from N,N-bis(2-chloroethyl)diisocyanato phosphoramide

Cancer is one of the most serious disease of human beings, and studies on antitumor drugs are still challenging scientists to look for new highly active compounds with low toxicity in this field. Cyclophosphamide (Endoxan), one of the most effective antitumor agents has been widely used in cancer chemotherapy¹. However, acrolein, from its metabolysis of hepatic mixed function oxidases in the liver, is toxic to the urinary system², hence,its clinical usage is restricted. With references to our previous works^3,4,we designed and synthesized a novel type of compounds Ⅰ with a nitrogen mustard group attached to the phosphorus atom of the heterocyclic ring in which the nitrogen atom at position 5 is from a α-substituted amino acid ester.     

Cytotoxic compounds from Polygala vulgaris

To search for antitumor agents from plants, we studied Polygala vulgaris since cytotoxic lignans are known to occur in some Polygala species. Preliminary data on plant petrol ether, chloroform, and methanol extracts from the roots and aerial parts, showed in vitro cytotoxic activity against the solid tumor LoVo cell line. Fractionation of the active extracts led to the isolation of three new compounds, a derivative of aucuparine and two xanthones, as well as a known methylsinapate. All compounds were tested for in vitro cytotoxic activity using two cell lines, LoVo and its strain, which express resistance to common antitumor agents.     

Acridine derivatives. V. Synthesis and P388 antitumor activity of the novel 9-anilino-2,3-ethylenedioxyacridines

A new class of deoxyribonucleic acid (DNA)-intercalating antitumor agents, novel 9-anilino-2,3-ethylenedioxyacridines (five compounds) have been synthesized and evaluated for activity against P388 leukemia in vivo. A few of them possessed the same potency of antitumor activity as amsacrine (m-AMSA) which is an important antitumor agent in clinical use.     

Halodemetallation of (Z)-1-[2-(Triarylstannyl)vinyl]-cyclooctanol and Correlation of Proton Chemical Shift with Electronegativity

IntroductionOrganotin compounds have attracted attentionas an optimal model for antitumour agents due tothe function of the interesting intramolecularO→Sn coordination[1,2 ] . Our recent concern hasbeen focused on the preparation of ( Z) - 1 - [2 -( triarylstannyl) vinyl]- cyclooctanol[3 ] .In order tofind more appropriate compounds used asanticancer agents and explore the effect of thecoordinate O→ Sn interaction to the antitumoractivity,the new compounds werehalodemetallated and characte…     

Syntheses of (E)- and (Z)-volkendousin

The first syntheses of the antitumor agents (E)-volkendousin (1) and acetonide 3 have been accomplished by efficient routes from readily available dehydroisoandrosterone (7) using allylic oxidation with SeO₂ to introduce the 4/gb-hydroxy group and 16-ketone. This sequence should make these compounds readily available for further biological evaluation.     

A robust LC–MS/MS method for the simultaneous determination of docetaxel and voriconazole in rat plasma and its application to pharmacokinetic studies

Opportunistic fungal infections are common in immunocompromised cancer patients, especially patients undergoing chemotherapy. Because antitumor agents are possible to combine with antifungal agents in clinical, it is necessary to study drug–drug interaction between antitumor agents and antifungal agents. The aim of the study was to explore a method for the simultaneous determination of voriconazole and docetaxel in plasma and investigate pharmacokinetic interaction of voriconazole and docetaxel in rats. A precise and reliable method using liquid chromatography tandem mass spectrometry (LC–MS/MS) was established for the simultaneous measure of docetaxel and voriconazole in rat plasma after liquid–liquid extraction with ethyl acetate. The method was fully validated and successfully applied to a pharmacokinetic interaction study of docetaxel and voriconazole in rats after single or combined administration. We found that the AUC of each drug after coadministration increased compared with that after the single administration, which might be caused by interaction at the absorption stage or the competitive inhibition on the metabolic enzymes. This established method can be utilized to study the detailed mechanism of the drug–drug interaction and guide rational drug use in the clinic.     

5-氟尿嘧啶-1-烷氧苯基三间氯苯基卟啉的合成及其体外抗癌活性

为提高5-氟尿嘧啶抗癌的靶向性,降低其不良反应,合成了5种新型卟啉-5-氟尿嘧啶衍生物及其Mn3+配合物,优化了合成反应条件,探索了目标化合物的分离方法。 通过IR、UV-Vis、1H NMR和ESI-MS对化合物结构和组成进行了确认。 采用四甲基偶氮唑蓝(MTT)比色法,以5-氟尿嘧啶为阳性对照药,测试了卟啉化合物对5种肿瘤细胞的体外抑制活性。 初筛结果显示,化合物D3对人卵巢癌细胞Sk-ov-3有较强的抑制作用。     

The Camptothecins: A Reborn Family of Antitumor Agents

A brief overview of the medicinal chemistry of the camptothecin family of antitumor agents is followed by a summary of a new synthetic approach to this class of compounds. This approach features a new 4 + 1 radical annulation.     

In Vivo Evaluation of (−)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site

Microtubule-stabilizing agents (MSAs) are a class of compounds used in the treatment of triple-negative breast cancer (TNBC), a subtype of breast cancer where chemotherapy remains the standard-of-care for patients. Taxanes like paclitaxel and docetaxel have demonstrated efficacy against TNBC in the clinic, however new classes of MSAs need to be identified due to the rise of taxane resistance in patients. (−)-Zampanolide is a covalent microtubule stabilizer that can circumvent taxane resistance in vitro but has not been evaluated for in vivo antitumor efficacy. Here, we determine that (−)-zampanolide has similar potency and efficacy to paclitaxel in TNBC cell lines, but is significantly more persistent due to its covalent binding. We also provide the first reported in vivo antitumor evaluation of (−)-zampanolide where we determine that it has potent and persistent antitumor efficacy when delivered intratumorally. Future work on zampanolide to further evaluate its pharmacophore and determine ways to improve its systemic therapeutic window would make this compound a potential candidate for clinical development through its ability to circumvent taxane-resistance mechanisms.     

Utilization of 2‐Chloronicotinonitrile in the Syntheses of Novel Fused Bicyclic and Polynuclear Heterocycles of Anticipated Antitumor Activity

Some of synthetic bicyclic and polynuclear heterocyclic compounds based on pyridine scaffold were tested as in vitro antitumor agents, and these compounds found to exhibit interesting activities. Fused heterocycles containing sulfur such as thienopyridine, pyridothiazine, and some related fused heterocycles as new ring systems were achieved. Bicyclic thienopyridine 6 and pyrido[3,2‐e][1,3]thiazin‐4(3H)‐one 7 exhibited good antitumor activities compared with 5‐fluorouracil.     

Synthesis and molecular docking of some new 3,5-bis-(diazipine,pyrazolopyrimidine, pyrimidine,and pyrazole) pyridine derivatives and their in vitro and in vivo biological evaluation as potential antitumor agents

Bis enaminone derivative 6 was reactive enaminone to synthesize new heterocyclic compounds containing diazipine, pyrazolopyrimidine, triazolopyrimidine, and pyrazole moieties by reaction with different bifunctional reagents. Structures of new compounds were confirmed by analytical and spectral data. Moreover, the new compounds were screened in-vitro as antitumor agents for Ehrlich ascites at different concentration. The results showed the compounds 18 , 19, and 20a have a good activity. In addition to, the molecular docking of these mentioned compounds was studied using vascular endothelial growth factor receptor.     

Total synthesis of fostriecin (CI-920).

The first total synthesis of the potent antitumor agent fostriecin (CI-920) is described, confirming the relative and absolute stereochemistry assignments. Fostriecin is a unique phosphate monoester which exhibits weak topoisomerase II inhibition (IC(50) = 40 microM) and more potent and selective protein phosphatase 2A and 4 (PP2A and PP4) inhibition (IC(50) = 40-3 nM and 1.5 nM), resulting in mitotic entry checkpoint inhibition. Phase I clinical trials with fostriecin, which were the first to explore the potential of this novel mechanism of action, were halted even before therapeutic concentrations were reached or dose-limiting toxicity established due to problems of drug stability observed during storage of naturally derived material. The synthesis of fostriecin detailed herein is the first stage of efforts that may serve to address these limitations to the clinical examination of this or related promising new antitumor agents.     

Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure–Activity Relationships

Diarylpentanoids, a class of natural products and their synthetic analogs which are structurally related to chalcones, have gained increasing attention due to their wide array of biological activities, including antitumor, anti-infective, antioxidant, anti-inflammatory, antidiabetic, anti-hyperuricemic, and neuroprotective properties. Previously, we reviewed diarylpentanoids with promising antitumor activity. However, in view of the wide range of biological activities described for this class of compounds, the purpose of this review is to provide a more detailed overview of the synthetic bioactive diarylpentanoids that have been described over the last two decades, beyond simply their antitumor effects. A total of 745 compounds were found, highlighting the main synthetic methodologies used in their synthesis as well as the structure–activity relationship studies and structural features for all activities reported. Collectively, this review highlights the diarylpentanoid scaffold as a promising starting point for the development of new therapeutic agents.     

Benzo[f]indole-4,9-dione Derivatives Effectively Inhibit the Growth of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor clinical outcome, and currently no effective targeted therapies are available. Indole compounds have been shown to have potential antitumor activity against various cancer cells. In the present study, we found that new four benzo[f]indole-4,9-dione derivatives reduce TNBC cell viability by reactive oxygen species (ROS) accumulation stress in vitro. Further analyses showed that LACBio1, LACBio2, LACBio3 and LACBio4 exert cytotoxic effects on MDA-MB 231 cancer cell line by inducing the intrinsic apoptosis pathway, activating caspase 9 and Bax/Bcl-2 pathway in vitro. These results provide evidence that these new four benzo[f]indole-4,9-dione derivatives could be potential therapeutic agents against TNBC by promoting ROS stress-mediated apoptosis through intrinsic-pathway caspase activation.     

Redox-active cobalt complexes as promising antitumor agents

Cobalt(iii) complexes with tetradentate aliphatic Schiff"s bases containing also compounds of the vitamin PP series or their analogs as axial ligands were synthesized as potential antitumor agents. The behavior of these redox-active complexes in chemical processes that presumably govern their biological action was studied. These processes include aquation and subsequent decomposition, electrode and homogeneous redox reactions, and catalytic activity in autooxidation of biosubstrates, especially at the stages of generation and consumption of reactive oxygen species (ROS). The antitumor action of these complexes in vivo was studied. Changes in the organisms of laboratory animals characteristic of processes involving ROS were followed at the cellular and molecular levels. The tumor-selective action of the complexes is due to specific features of microenvironment of tumor cells. Some of them exhibit a strong antimetastatic effect, which exceeds that for a number of drugs used in clinical practice. A complex with nicotinamide was recommended for preclinical studies. The scope of application of the redox-active transition metal complexes in oncology is discussed.